The association between body mass index and non-metastatic breast cancer disease free survival (DFS) and distant metastasis free survival (DMFS) in hormone receptor positive postmenopausal women treated with aromatase inhibitors
Obesity is a major health concern; research has linked obesity to increased breast cancer risk and poor survival outcome in postmenopausal women with hormone receptor–positive disease. Suggesting that adiposity may reduce the therapeutic efficacy of endocrine therapies, leading to higher risks of recurrence....